Marenzi G, Assanelli E, Marana I, Lauri G,Campodonico J, Grazi M

Transcription

Marenzi G, Assanelli E, Marana I, Lauri G,Campodonico J, Grazi M
Solmucol Comprimés effervescents
Marenzi G, Assanelli E, Marana I, Lauri G,Campodonico J, Grazi M, De Metrio M, Galli S,
Fabbiocchi F, et al. N-Acetylcysteine and contrast-induced nephropathy in primary angioplasty. N
Engl J Med.354: 2773-82; 2006.
Tirouvanziam R, Conrad K. C, Bottiglieri T, Herzenberg A. L, Moss B. R, et al. High-dose oral
N-Acetylcysteine, a glutathione prodrug,modulates inflammation in cystyc fibrosis. PNAS. 103:
4628-4633; 2006.
Demedts M, Behr J, Buhl R, Costabel U, Dekhuijzen R, Jensen M.H, MacNee W, Thomeer M,
Wallaert B, et al. High-dose acetylcysteine in idiopathic pulmonary fibrosis. N Engl J Med. 353:
2229-42; 2005.
Tepel M, van der Giet M, Statz M, Jankowski J, Zidek W. The antioxidant acetylcysteine reduces
cardiovascular events in patients with end-stage renal failure. A Randomized, Controlled Trial.
Circulation.107: 992-995; 2003.
Brophy F. D. Role of N-Acetylcysteine in the prevention of radiocontrast induced nephropathy. The
Annals of Pharmacotherapy. 36: 1466-70; 2002.
Russi E. W, Leuenberger Ph, Brändli O, Frey F. G, Grebski E, Gugger M, Paky A, Pons M, Karrer
M, Kubn M, Rochat Th, Schibli R, Solèr M, Wacker F. Management of chronic obstructive
pulmonary disease:the Swiss guidelines. SWISS MED WKLY. 132: 67-78; 2002.
Poole J. P, Black N. P. Oral mucolytic drugs for exacerbations of chronic obstructive pulmonary
disease: systematic review. BMJ. 322: 1-6; 2001.
Stey C, Steurer J, Bachmann S, Medici T. C, Tramèr M. R. The effect of oral N-acetylcysteine in
chronic bronchitis: a quantitative systematic review. European Respiratory Journal.16: 253-262;
2000.
Tepel M, van der Giet M, Schwarzfeld C, Laufer U, Liermann D, Zidek W. Prevention of
radiographic-contrast-agent-induced reductions in renal function byacetylcysteine. The New
England Journal of Medicine. 180-184; 2000.
Del Donno, M., Cacciani, G.C., Greco, F., Olivieri, D. N-Acetylcystein bei Patienten mit
broncho-obstruktivem Syndrom. Therapiewoche Schweiz 7 (9): 628 - 632; 1991.
Grasso, L., Mautone, G., Scarazatti, E., Lualdi, P. Les comprimés à sucer de N-acétylcystéine
édulcorés au xylitol n'induisent pas la formation de plaque dentaire. Rev. Mens. Suisse
Odontostomatol. 100: 617 - 619; 1990.
De Bernardi di Valserra, M., Mautone, G., Barindelli, E., Lualdi, P., Feletti, F., Galmozzi, M.R.
Bioavailability of suckable tablets of oral N-acetytylcysteine in man. Eur. J. Clin. Pharmacol. 37:
419 - 421; 1989.
Copyright
Fourtillan, J.B., Saux, M.C., Ingrand, I., Couraud, L. Influence de la N-acétylcystéine sur la
diffusion de l'amoxicilline dans les tissus pulmonaires et bronchiques. J. Pharm. Clin. 9: 37 - 39;
1989.
© 2013 IBSA Institut Biochimique SA

Documents pareils